CNS pipeline · person
Patrick Machado, JD
Director of Xenon Pharmaceuticals since November 2020 and a member of the Audit and Compensation Committees. He co-founded and served as CFO and Chief Business Officer of Medivation until 2014, helping lead the clinical development and launch of XTANDI. He holds a J.D. from Harvard Law School.
- 1 company
Current roles
- Xenon Pharmaceuticals Inc.Director · Board
Appears with
People sharing a company with Patrick.
- Andrea DiFabio · Xenon Pharmaceuticals Inc.
- Christopher Kenney · Xenon Pharmaceuticals Inc.
- Darren Cline · Xenon Pharmaceuticals Inc.
- Dawn Svoronos · Xenon Pharmaceuticals Inc.
- Elizabeth Garofalo · Xenon Pharmaceuticals Inc.
- Gary Patou · Xenon Pharmaceuticals Inc.
- Gillian Cannon · Xenon Pharmaceuticals Inc.
- Ian Mortimer · Xenon Pharmaceuticals Inc.
- James Empfield · Xenon Pharmaceuticals Inc.
- Justin Gover · Xenon Pharmaceuticals Inc.
- Matthew D. Ronsheim · Xenon Pharmaceuticals Inc.
- Michael Hayden · Xenon Pharmaceuticals Inc.
- Robin Sherrington · Xenon Pharmaceuticals Inc.
- Shelley McCloskey · Xenon Pharmaceuticals Inc.
- Steven Gannon · Xenon Pharmaceuticals Inc.
- Tucker Kelly · Xenon Pharmaceuticals Inc.
People and affiliation data assembled from public company disclosures, SEC filings, and conference materials — every record source-cited under psychiatrist-authored guardrails.